Back to Search
Start Over
Effects of different transdermal penetration enhancers applied to herbal cake-partitioned moxibustion on liver lipids, HSL and HMG-CoA reductase in hyperlipidemia rabbits
- Source :
- Journal of Acupuncture and Tuina Science. 18:157-164
- Publication Year :
- 2020
- Publisher :
- Springer Science and Business Media LLC, 2020.
-
Abstract
- To observe the effects of laurocapram and borneol as transdermal penetration enhancers applied to herbal cake-partitioned moxibustion on liver lipids, hormone-sensitive lipase (HSL) and hydroxymethylglutaryl CoA (HMG-CoA) reductase in hyperlipidemia rabbits. Forty New-Zealand rabbits were randomly divided into 5 groups using the random number table method, with 8 rats in each group. Rabbits in the blank group were fed routinely with a normal diet; rabbits in the other groups were fed with high-fat diet for 12 weeks to establish the hyperlipidemia model. Rabbits in the blank and the model groups were not given any intervention. After the model was prepared successfully, rabbits in the non-transdermal penetration enhancer group received herbal cake-partitioned moxibustion without transdermal penetration enhancers; rabbits in the laurocapram group and the borneol group received herbal cake-partitioned moxibustion with laurocapram or borneol respectively. After 4 weeks of treatment, the serum was isolated and enzyme-linked immunosorbent assay (ELISA) was applied for the detection of HSL and HMG-CoA reductase. The liver tissues were isolated, and total cholesterol (TC) and triglycerides (TG) were measured by enzymatic methods. One-step method was applied for high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) detection, and transmission turbidimetry was for apolipoprotein A1 (Apo-A1) and apolipoprotein B (Apo-B) detection. The serum concentrations of the drugs in the laurocapram and the borneol groups were significantly higher than those in the non-transdermal penetration enhancer group (both P
- Subjects :
- biology
Apolipoprotein B
Normal diet
business.industry
Laurocapram
0211 other engineering and technologies
02 engineering and technology
Pharmacology
Reductase
medicine.disease
030205 complementary & alternative medicine
Borneol
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Complementary and alternative medicine
chemistry
021105 building & construction
HMG-CoA reductase
Hyperlipidemia
biology.protein
Medicine
lipids (amino acids, peptides, and proteins)
Apolipoprotein A1
business
Subjects
Details
- ISSN :
- 19930399 and 16723597
- Volume :
- 18
- Database :
- OpenAIRE
- Journal :
- Journal of Acupuncture and Tuina Science
- Accession number :
- edsair.doi...........831b5c1f808980f66516ea16ac5ee788